Prrx2-KO Mouse
Common Name
Prrx2-KO
제품 ID
S-KO-18674
Backgroud
C57BL/6JCya
품종 계통계통 ID
KOCMP-20204-Prrx2-B6J-VA
상태
이 마우스 계통을 논문에서 사용할 경우, “Prrx2-KO Mouse (카탈로그 번호 S-KO-18674)은 Cyagen에서 구입하였습니다.”라고 명시해 주시기 바랍니다.
구매 가능한 제품 종류
연령
Genotype
성별
수량
표준 제공 조건은 최소 3마리의 이형접합(heterozygous) 보균자를 보장합니다. 동형접합(homozygous) 보균자 및/또는 특정 성별에 대한 브리딩 서비스도 제공됩니다.
기본 정보
품종 계통
Prrx2-KO
품종 계통계통 ID
KOCMP-20204-Prrx2-B6J-VA
유전자명
제품 ID
S-KO-18674
유전자 별칭
S8, Prx2
배경
C57BL/6JCya
NCBI ID
변형 내용
Conventional knockout
염색체
Chr 2
Phenotype
Datasheet
적용 분야
--
품종 계통 설명
Ensembl 전사체 ID
ENSMUST00000041659
NCBI 전사체 ID
NM_009116
타겟 영역
Exon 2
유효 영역 크기
~1.3 kb
유전자 연구 개요
Prrx2, the paired-related homeobox transcription factor, has been implicated in multiple biological processes. It participates in regulating gene expression and is associated with pathways like Wnt/β -catenin, TGF -β, and Hippo. Prrx2 is important in cell differentiation, proliferation, and in processes related to various diseases, making genetic models valuable for studying its functions [2,3,4,6,8,9].
Silencing Prrx2 in breast cancer cells inhibited their proliferation and growth in vitro and in vivo, and also down-regulated the Wnt/β -catenin signaling pathway, suggesting its oncogenic role in breast cancer [8]. In colon cancer, inhibition of Prrx2 reduced the invasive and migrating abilities of cells, hindered epithelial-mesenchymal transition (EMT), and suppressed liver metastasis through inactivation of the Wnt/β -catenin pathway [6]. Myoblast-derived exosomal Prrx2 enhanced osteogenic differentiation of bone marrow-derived mesenchymal stem cells (BMSCs) by transcriptionally regulating lncRNA-MIR22HG to activate the Hippo pathway, alleviating osteoporosis in mice [2]. In glioblastoma, circLRFN5 binds to Prrx2 protein and promotes its degradation, suppressing glioblastoma progression as Prrx2 transcriptionally upregulates GCH1, a ferroptosis suppressor [1]. In prostate cancer, activation of Prrx2 promoted enzalutamide resistance, and its expression was highest in double-negative prostate cancer, correlating with reduced overall survival [3]. In lung adenocarcinoma, Prrx2 was highly expressed, acting as a positive regulator of cell proliferation and a negative regulator of apoptosis by binding to the PSMD1 promoter [4]. Silencing Marveld3 upregulated Prrx2, which attenuated radiation-induced lipid peroxidation in skin cells, potentially protecting against radiation-induced ferroptosis [5]. In neuropathic pain, a spinal-specific super enhancer regulated chronic constriction injury-induced neuropathic pain by driving Prrx2 transcription in dorsal horn neurons, and knocking down Prrx2 alleviated neuropathic pain behaviors [7]. In odontoblast differentiation, Prrx2 may regulate pannexin 3 expression [10].
In conclusion, Prrx2 is involved in diverse biological functions such as cell proliferation, differentiation, and apoptosis. Through model-based research, its role in diseases like cancer, osteoporosis, radiation-induced skin injury, and neuropathic pain has been revealed. These findings provide insights into potential therapeutic targets for these diseases.
References:
1. Jiang, Yang, Zhao, Junshuang, Li, Rongqing, Gao, Liang, Cui, Daming. 2022. CircLRFN5 inhibits the progression of glioblastoma via PRRX2/GCH1 mediated ferroptosis. In Journal of experimental & clinical cancer research : CR, 41, 307. doi:10.1186/s13046-022-02518-8. https://pubmed.ncbi.nlm.nih.gov/36266731/
2. Li, Yunchao, Wang, Xiaoxiao, Pan, Changyu, Chen, Zejun, He, Haoyu. 2023. Myoblast-derived exosomal Prrx2 attenuates osteoporosis via transcriptional regulation of lncRNA-MIR22HG to activate Hippo pathway. In Molecular medicine (Cambridge, Mass.), 29, 54. doi:10.1186/s10020-023-00649-y. https://pubmed.ncbi.nlm.nih.gov/37081396/
3. Rodríguez, Yara, Unno, Kenji, Truica, Mihai I, Han, Huiying, Abdulkadir, Sarki A. . A Genome-Wide CRISPR Activation Screen Identifies PRRX2 as a Regulator of Enzalutamide Resistance in Prostate Cancer. In Cancer research, 82, 2110-2123. doi:10.1158/0008-5472.CAN-21-3565. https://pubmed.ncbi.nlm.nih.gov/35405009/
4. Liu, Lihua, Liu, Aihua, Liu, Xuezheng. 2022. PRRX2 predicts poor survival prognosis, and promotes malignant phenotype of lung adenocarcinoma via transcriptional activates PSMD1. In Translational oncology, 27, 101586. doi:10.1016/j.tranon.2022.101586. https://pubmed.ncbi.nlm.nih.gov/36379103/
5. Cao, Jinming, Wu, Mengyao, Mo, Wei, Zhang, Bin, Cao, Jianping. 2024. Upregulation of PRRX2 by silencing Marveld3 as a protective mechanism against radiation-induced ferroptosis in skin cells. In Molecular medicine (Cambridge, Mass.), 30, 182. doi:10.1186/s10020-024-00958-w. https://pubmed.ncbi.nlm.nih.gov/39434056/
6. Chai, Wen-Xiao, Sun, Li-Guo, Dai, Fu-Hong, Zheng, Ning-Gang, Cai, Hong-Yi. 2019. Inhibition of PRRX2 suppressed colon cancer liver metastasis via inactivation of Wnt/β-catenin signaling pathway. In Pathology, research and practice, 215, 152593. doi:10.1016/j.prp.2019.152593. https://pubmed.ncbi.nlm.nih.gov/31471104/
7. Tao, Yang, Wang, Qi-Hui, Li, Xiao-Tong, Cao, Jun-Li, Pan, Zhiqiang. 2023. Spinal-Specific Super Enhancer in Neuropathic Pain. In The Journal of neuroscience : the official journal of the Society for Neuroscience, 43, 8547-8561. doi:10.1523/JNEUROSCI.1006-23.2023. https://pubmed.ncbi.nlm.nih.gov/37802656/
8. Lü, Z D, Yang, Z C, Jin, L Y, Kong, B, Wang, H B. . [Effects of Prrx2 gene silencing on the proliferation of breast cancer and its molecular mechanisms]. In Zhonghua yi xue za zhi, 100, 942-946. doi:10.3760/cma.j.cn112137-20190710-01309. https://pubmed.ncbi.nlm.nih.gov/32234171/
9. Juang, Yu-Lin, Jeng, Yung-Ming, Chen, Chi-Long, Lien, Huang-Chun. 2016. PRRX2 as a novel TGF-β-induced factor enhances invasion and migration in mammary epithelial cell and correlates with poor prognosis in breast cancer. In Molecular carcinogenesis, 55, 2247-2259. doi:10.1002/mc.22465. https://pubmed.ncbi.nlm.nih.gov/26824226/
10. Tanaka, Manami, Sugimoto, Asuna, Iwata, Kokoro, Oishi, Atsushi, Iwamoto, Tsutomu. 2024. Prrx2, the paired-related homeobox transcription factor, functions as a potential regulator of pannexin 3 expression in odontoblast differentiation. In Journal of oral biosciences, 67, 100601. doi:10.1016/j.job.2024.100601. https://pubmed.ncbi.nlm.nih.gov/39733924/
품질 관리 기준
정자 검사
동결 보존 전: 정자 농도 측정 및 정자 생존율 평가.
동결 보존 후: 각 배치에서 동결 보존된 정자 바이알 1개를 선택하여 체외수정(in vitro fertilization)에 사용합니다.
Environmental Standards:
SPFAvailable Region:
GlobalSource:
Cyagen문의하기
맞춤형 동물 모델 관련 상담을 위해 Cyagen 전문가와 연락해 보세요. 아래 양식을 작성하여 상담을 시작하거나 견적을 요청하시기 바랍니다.
Cyagen은 고객님의 개인정보를 소중히 여깁니다. 최신 제품, 서비스 및 인사이트를 안내드리고자 합니다. 고객님의 수신 설정은 다음과 같습니다:
해당 커뮤니케이션은 언제든지 수신 거부하실 수 있습니다. 수신 거부 방법 및 데이터 보호에 대한 자세한 내용은 개인정보처리방침을 참고해 주시기 바랍니다.
아래 버튼을 클릭함으로써, 요청하신 콘텐츠 제공을 위해 본 양식을 통해 제출된 개인정보를 Cyagen이 저장 및 처리하는 데 동의하게 됩니다.
